Cargando…
Single-dose SARS-CoV-2 vaccinations with either BNT162b2 or AZD1222 induce disparate Th1 responses and IgA production
BACKGROUND: While vaccination programs against the severe acute respiratory syndrome virus 2 (SARS-CoV-2) are globally ongoing, disparate strategies for the deployment of spike antigen show varying effectiveness. METHODS: In order to explore this phenomenon, we sought to compare the early immune res...
Autores principales: | Müller, Michael, Volzke, Johann, Subin, Behnam, Müller, Silke, Sombetzki, Martina, Reisinger, Emil C., Müller-Hilke, Brigitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766223/ https://www.ncbi.nlm.nih.gov/pubmed/35042529 http://dx.doi.org/10.1186/s12916-022-02240-4 |
Ejemplares similares
-
Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2
por: Müller-Hilke, Brigitte, et al.
Publicado: (2022) -
Distinguishing Incubation and Acute Disease Stages of Mild-to-Moderate COVID-19
por: Müller, Michael, et al.
Publicado: (2022) -
Comparison of Neutralizing Antibody Responses at 6 Months Post Vaccination with BNT162b2 and AZD1222
por: Terpos, Evangelos, et al.
Publicado: (2022) -
AZD-1222: IgA-nephropathy: case report
Publicado: (2022) -
Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222
por: Perkmann, Thomas, et al.
Publicado: (2021)